Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Nov / Huntington’s Disease Mechanism: New Insights
Neurology Neurology Precision medicine Biochemistry and molecular biology

Huntington’s Disease Mechanism: New Insights

How chemical changes in the brain could inform early diagnostic tests

By Helen Bristow 11/05/2024 News 1 min read

Share

Researchers from the University of Oxford have discovered biochemical changes that occur in the development of Huntington’s disease (HD) – and they could be the key to its early detection.

Credit: Adobe Stock

HD is an inherited neurodegenerative disorder, typically with adult onset, that affects both cognitive function and movement, and is usually fatal after around 20 years. Diagnosis is via genetic testing from a blood sample, but often prompted by advanced disease.

The study, published in Nature Metabolism, investigated how disruptions in glutathione-ascorbate metabolism in brain neurons can trigger early dopamine dysfunction and disrupted motor function associated with HD.

Glutathione-ascorbate metabolism has previously been associated with specific neurons in the brain, called indirect pathway spiny projection neurons (iSPNs). In mouse models, the team observed that, when TrkB signaling in iSPNs was disrupted, dopamine production increased, leading to hyperactivity. The researchers also found that, early in the development of HD in mice, levels of an enzyme called GSTO2 increase. Elevated levels of this enzyme – which is also linked to glutathione ascorbate metabolism – also result in higher dopamine levels than normal, which affects movement and mood. When the scientists reduced the GSTO2 levels in specific brain cells in mice, they found it helped keep dopamine levels steady and stopped early movement issues.

The results suggest that detection of changes in GSTO2 and similar processes could lead to earlier diagnosis of HD. Lead author, Liliana Minichiello, commented, “‘This research marks the first time that we have been able to identify a specific chemical change that is unique to the development of Huntington’s disease, which opens the possibility of developing new tests to study the early changes of the disease before irreversible damage occurs.”

Greater understanding of the mechanisms by which GSTO2 affects dopamine in these early stages could also point to it being a helpful marker or target for slowing down HD’s effects on movement and brain function.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Shapeshifting Cancer
Neurology
The Shapeshifting Cancer

February 24, 2022

1 min read

Understanding the heterogeneity and plasticity of glioblastoma

Image of the Month
Neurology
Image of the Month

October 21, 2016

1 min read

Who Will Be The Caretakers?
Neurology
Who Will Be The Caretakers?

August 4, 2022

3 min read

Recent allegations of image manipulation in a major Alzheimer’s disease paper reaffirm the importance of research integrity

Getting to the Genetic Core of Autism
Neurology
Getting to the Genetic Core of Autism

August 15, 2022

2 min read

Investigating the genotype-phenotype relationship in autism to improve our understanding of heterogeneity

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.